Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $70.83 million. The enterprise value is $146.76 million.
| Market Cap | 70.83M |
| Enterprise Value | 146.76M |
Important Dates
The last earnings date was Monday, June 8, 2026, after market close.
| Earnings Date | Jun 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.66 million shares outstanding. The number of shares has decreased by -1.66% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.66M |
| Shares Change (YoY) | -1.66% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 35.24% |
| Owned by Institutions (%) | 25.92% |
| Float | 6.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 46.06 |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.88 |
| Quick Ratio | 0.39 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.73 |
Financial Efficiency
Return on equity (ROE) is -18.76% and return on invested capital (ROIC) is -10.41%.
| Return on Equity (ROE) | -18.76% |
| Return on Assets (ROA) | -3.37% |
| Return on Invested Capital (ROIC) | -10.41% |
| Return on Capital Employed (ROCE) | -11.89% |
| Weighted Average Cost of Capital (WACC) | 7.37% |
| Revenue Per Employee | $356,366 |
| Profits Per Employee | -$52,385 |
| Employee Count | 763 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.64 |
Taxes
In the past 12 months, Zepp Health has paid $2.64 million in taxes.
| Income Tax | 2.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +112.31% in the last 52 weeks. The beta is 1.78, so Zepp Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +112.31% |
| 50-Day Moving Average | 11.13 |
| 200-Day Moving Average | 25.62 |
| Relative Strength Index (RSI) | 29.19 |
| Average Volume (20 Days) | 221,790 |
Short Selling Information
The latest short interest is 338,537, so 5.27% of the outstanding shares have been sold short.
| Short Interest | 338,537 |
| Short Previous Month | 354,079 |
| Short % of Shares Out | 5.27% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, Zepp Health had revenue of $271.91 million and -$39.97 million in losses. Loss per share was -$2.56.
| Revenue | 271.91M |
| Gross Profit | 104.27M |
| Operating Income | -28.35M |
| Pretax Income | -37.33M |
| Net Income | -39.97M |
| EBITDA | -23.93M |
| EBIT | -28.35M |
| Loss Per Share | -$2.56 |
Balance Sheet
The company has $52.40 million in cash and $128.33 million in debt, with a net cash position of -$75.93 million or -$5.18 per share.
| Cash & Cash Equivalents | 52.40M |
| Total Debt | 128.33M |
| Net Cash | -75.93M |
| Net Cash Per Share | -$5.18 |
| Equity (Book Value) | 194.17M |
| Book Value Per Share | 12.23 |
| Working Capital | -35.00M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.41M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.35%, with operating and profit margins of -10.43% and -14.70%.
| Gross Margin | 38.35% |
| Operating Margin | -10.43% |
| Pretax Margin | -13.73% |
| Profit Margin | -14.70% |
| EBITDA Margin | -8.80% |
| EBIT Margin | -10.43% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.66% |
| Shareholder Yield | 1.66% |
| Earnings Yield | -56.43% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Zepp Health is $56.28, which is 1,065.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.28 |
| Price Target Difference | 1,065.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Zepp Health has an Altman Z-Score of 0.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.75 |
| Piotroski F-Score | 2 |